FARFUM-RoP, A dataset for computer-aided detection of Retinopathy of Prematurity

Morteza Akbari1, Hamid-Reza Pourreza2,3, Elias Khalili Pour4

  • 1Machine Vision Lab., Faculty of Engineering, Ferdowsi University of Mashhad, Mashhad, 9177948974, Iran.

Scientific Data
|October 31, 2024
PubMed

Insights

A new public dataset, FARFUM-RoP, aids Retinopathy of Prematurity (ROP) research. This dataset supports AI development for detecting Plus Disease, a severe form of ROP in premature infants.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Retinopathy of Prematurity (ROP) is a leading cause of blindness in premature infants, stemming from abnormal retinal blood vessel development.
  • Plus Disease signifies severe ROP, crucial for timely diagnosis and intervention.
  • Artificial Intelligence (AI) shows promise in ROP detection, but requires high-quality, diverse datasets.

Purpose of the Study:

  • To introduce FARFUM-RoP, a novel, publicly available dataset for ROP research.
  • To facilitate the development and validation of AI algorithms for ROP and Plus Disease detection.
  • To promote collaboration and data sharing within the ROP research community.

Main Methods:

  • The FARFUM-RoP dataset contains 1533 ROP fundus images from 68 patients.
  • Images were independently annotated by five experienced childhood ophthalmologists.
  • Annotations include classifications of 'Normal,' 'Pre-Plus,' and 'Plus' disease stages.

Main Results:

  • The dataset provides a valuable resource for training and testing AI models.
  • Expert annotations offer a robust ground truth for evaluating AI performance in identifying ROP severity.
  • The dataset adheres to ethical principles, with patient consent obtained for data collection.

Conclusions:

  • The FARFUM-RoP dataset represents a significant contribution to ROP research.
  • Availability of this dataset will accelerate AI-driven advancements in diagnosing and managing ROP.
  • This resource supports the development of more accurate and accessible ROP screening tools.